Overall, our findings reproduce the claims of many prior reports, suggest a potential role of folate metabolism in keloid pathogenesis, and present some of the first insights into the metabolic consequences of monogenic loss of STAT3 activity. The gene discussed is STAT3; the disease is keloid.